PART 1 – FINANCIAL INFORMATION
ITEM 1.FINANCIAL STATEMENTS
JONES SODA CO.
CONDENSED CONSOLIDATED BALANCE SHEETS
| | | | | | |
| | March 31, 2017 | | December 31, 2016 |
| | (Unaudited) | | | |
| | (In thousands, except share data) |
ASSETS | | | | | | |
Current assets: | | | | | | |
Cash and cash equivalents | | $ | 554 | | $ | 733 |
Accounts receivable, net of allowance of $15 and $13 | | | 2,044 | | | 2,174 |
Inventory | | | 2,127 | | | 1,850 |
Prepaid expenses and other current assets | | | 124 | | | 142 |
Total current assets | | | 4,849 | | | 4,899 |
Fixed assets, net of accumulated depreciation of $557 and $922 | | | 23 | | | 25 |
Other assets | | | 8 | | | 8 |
Total assets | | $ | 4,880 | | $ | 4,932 |
LIABILITIES AND SHAREHOLDERS’ EQUITY | | | | | | |
Current liabilities: | | | | | | |
Accounts payable | | $ | 1,853 | | $ | 1,049 |
Line of credit | | | 634 | | | 1,205 |
Accrued expenses | | | 705 | | | 835 |
Taxes payable | | | 9 | | | 26 |
Total current liabilities | | | 3,201 | | | 3,115 |
Deferred rent | | | 12 | | | 12 |
Shareholders’ equity: | | | | | | |
Common stock, no par value: | | | | | | |
Authorized — 100,000,000; issued and outstanding shares — 41,379,373 shares and 41,340,727 shares, respectively | | | 53,788 | | | 53,772 |
Additional paid-in capital | | | 8,715 | | | 8,674 |
Accumulated other comprehensive income | | | 221 | | | 219 |
Accumulated deficit | | | (61,057) | | | (60,860) |
Total shareholders’ equity | | | 1,667 | | | 1,805 |
Total liabilities and shareholders’ equity | | $ | 4,880 | | $ | 4,932 |
See accompanying notes to condensed consolidated financial statements.
JONES SODA CO.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
| | | | | |
| Three months ended March 31, |
| 2017 | | 2016 |
| (In thousands, except share data) |
Revenue | $ | 3,535 | | $ | 4,274 |
Cost of goods sold | | 2,682 | | | 3,102 |
Gross profit | | 853 | | | 1,172 |
Operating expenses: | | | | | |
Selling and marketing | | 544 | | | 542 |
General and administrative | | 483 | | | 564 |
| | 1,027 | | | 1,106 |
Income (loss) from operations | | (174) | | | 66 |
Interest expense | | (15) | | | (22) |
Other (expense) income, net | | (1) | | | 12 |
Income (loss) before income taxes | | (190) | | | 56 |
Income tax expense, net | | (7) | | | (7) |
Net income (loss) | $ | (197) | | $ | 49 |
| | | | | |
Net income (loss) per share - basic | $ | (0.00) | | $ | 0.00 |
Net income (loss) per share - diluted | $ | (0.00) | | $ | 0.00 |
Weighted average basic common shares outstanding | | 41,367,662 | | | 41,314,894 |
Weighted average diluted common shares outstanding | | 41,367,662 | | | 41,628,078 |
See accompanying notes to condensed consolidated financial statements.
JONES SODA CO.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
| | | | | | |
| | |
| | Three months ended March 31, |
| | 2017 | | 2016 |
| | (In thousands) |
Net income (loss) | | $ | (197) | | $ | 49 |
Other comprehensive income (loss): | | | | | | |
Foreign currency translation adjustment gain | | | 2 | | | 20 |
Total comprehensive income (loss) | | $ | (195) | | $ | 69 |
See accompanying notes to condensed consolidated financial statements.
JONES SODA CO.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| | | | | | |
| | Three months ended March 31, |
| | 2017 | | 2016 |
| | (In thousands) |
OPERATING ACTIVITIES: | | | | | | |
Net income (loss) | | $ | (197) | | $ | 49 |
Adjustments to reconcile net income (loss) to net cash used | | | | | | |
in operating activities: | | | | | | |
Depreciation and amortization | | | 3 | | | 4 |
Stock-based compensation | | | 42 | | | 29 |
Change in allowance for doubtful accounts | | | 2 | | | 11 |
Changes in operating assets and liabilities: | | | | | | |
Accounts receivable | | | 123 | | | (561) |
Inventory | | | (277) | | | (193) |
Prepaid expenses and other current assets | | | 18 | | | 8 |
Accounts payable | | | 804 | | | 294 |
Accrued expenses | | | (130) | | | 286 |
Taxes payable | | | (17) | | | 5 |
Other liabilities | | | - | | | 1 |
Net cash provided by (used in) operating activities | | | 371 | | | (67) |
FINANCING ACTIVITIES: | | | | | | |
Proceeds from exercise of stock options | | | 16 | | | - |
Payment of capital lease obligations | | | - | | | (2) |
Proceeds from line of credit, net of repayments | | | (571) | | | (6) |
Net cash used in financing activities | | | (555) | | | (8) |
Net decrease in cash and cash equivalents | | | (184) | | | (75) |
Effect of exchange rate changes on cash | | | 5 | | | 2 |
Cash and cash equivalents, beginning of period | | | 733 | | | 772 |
Cash and cash equivalents, end of period | | $ | 554 | | $ | 699 |
Supplemental disclosure: | | | | | | |
Cash paid during period for: | | | | | | |
Interest | | $ | 15 | | $ | 22 |
Income taxes | | | 23 | | | - |
See accompanying notes to condensed consolidated financial statements.
JONES SODA CO.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Nature of Operations and Summary of Significant Accounting Policies
Jones Soda Co. develops, produces, markets and distributes premium beverages, which it sells and distributes primarily in the United States and Canada through its network of independent distributors and directly to its national and regional retail accounts.
We are a Washington corporation and have two operating subsidiaries, Jones Soda Co. (USA) Inc. and Jones Soda (Canada) Inc. (the “Subsidiaries”).
Basis of presentation and consolidation
The accompanying condensed consolidated balance sheet as of December 31, 2016, which has been derived from our audited consolidated financial statements, and unaudited interim condensed consolidated financial statements as of March 31, 2017, has been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the Securities and Exchange Commission (SEC) rules and regulations applicable to interim financial reporting. The condensed consolidated financial statements include our accounts and accounts of our Subsidiaries. All intercompany transactions between us and our Subsidiaries have been eliminated in consolidation.
In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all material adjustments, consisting only of those of a normal recurring nature, considered necessary for a fair presentation of our financial position, results of operations and cash flows at the dates and for the periods presented. The operating results for the interim periods presented are not necessarily indicative of the results expected for the full year. These financial statements should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.
Liquidity
As of March 31, 2017, we had cash and cash equivalents of approximately $554,000 and working capital of $1.6 million. Cash provided by operations during the three months ended March 31, 2017 totaled $371,000 compared to cash used in operations of $67,000 for the same period a year ago. The increase in cash provided by operations compared to the same period a year ago is primarily due to the timing of production and certain receivables. We reported a net loss of $197,000 for the three months ended March 31, 2017.
As of the date of this Report, we believe that our current cash and cash equivalents, combined with available borrowings under our Loan Facility and anticipated cash from operations, will be sufficient to meet our anticipated cash needs through March 31, 2018.
We have a revolving secured credit facility (the “Loan Facility”) with CapitalSource Business Finance Group. The Loan Facility allows us to borrow a maximum aggregate amount of up to $3.2 million based on eligible accounts receivable and inventory. As of March 31, 2017, our accounts receivable and inventory eligible borrowing base was approximately $1.9 million, of which we had drawn down approximately $634,000. See Note 3 for further information.
We may require additional financing to support our working capital needs in the future. The amount of additional capital we may require, the timing of our capital needs and the availability of financing to fund those needs will depend on a number of factors, including our strategic initiatives and operating plans, the performance of our business and the market conditions for available debt or equity financing. Additionally, the amount of capital required will depend on our ability to meet our case sales goals and otherwise successfully execute our operating plan. We believe it is imperative that we meet these sales objectives in order to lessen our reliance on external financing in the future. We intend to continually monitor and adjust our business plan as necessary to respond to developments in our business, our markets and the broader economy. Although we believe various debt and equity financing alternatives will be available to us to support our working capital needs, financing arrangements on acceptable terms may not be available to us when needed. Additionally, these alternatives may require significant cash payments for interest and other costs or could be highly dilutive to our existing shareholders. Any such financing alternatives may not provide us with sufficient funds to meet our long-term capital requirements. If necessary, we may explore strategic transactions that we consider to be in the best interest of the Company and our shareholders, which may include, without limitation, public or private offerings of debt or equity securities, a rights offering, and other strategic alternatives; however, these options may not ultimately be available or feasible.
The uncertainties relating to our ability to successfully execute on our business plan and finance our operations continue to raise substantial doubt about our ability to continue as a going concern. Our financial statements for the periods presented were prepared assuming we would continue as a going concern, which contemplates that we will continue in operation for the
foreseeable future and will be able to realize assets and settle liabilities and commitments in the normal course of business. These financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that could result should we be unable to continue as a going concern.
Seasonality and other fluctuations
Our sales are seasonal and we experience fluctuations in quarterly results as a result of many factors. We historically have generated a greater percentage of our revenues during the warm weather months of April through September. Sales may fluctuate materially on a quarter to quarter basis or an annual basis when we launch a new product or fill the “pipeline” of a new distribution partner or a large retail partner such as 7-Eleven. Sales results may also fluctuate based on the number of SKUs selected or removed by our distributors and retail partners through the normal course of serving consumers in the dynamic, trend-oriented beverage industry. As a result, management believes that period-to-period comparisons of results of operations are not necessarily meaningful and should not be relied upon as any indication of future performance or results expected for the fiscal year.
Net income (loss) per share
The computation for basic and diluted earnings per share is as follows (in thousands, except share data):
| | | | | |
| Three months ended March 31, |
| 2017 | | 2016 |
Net income (loss) | $ | (197) | | $ | 49 |
Weighted average common shares outstanding: | | | | | |
Basic | | 41,367,662 | | | 41,314,894 |
Dilutive stock options | | - | | | 313,184 |
Diluted | | 41,367,662 | | | 41,628,078 |
Net income (loss) per share: | | | | | |
Basic | $ | (0.00) | | $ | 0.00 |
Diluted | $ | (0.00) | | $ | 0.00 |
Use of estimates
The preparation of the condensed consolidated financial statements requires management to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, inventory valuation, depreciable lives and valuation of capital assets, valuation allowances for receivables, trade promotion liabilities, stock-based compensation expense, valuation allowance for deferred income tax assets, contingencies, and forecasts supporting the going concern assumption and related disclosures. Actual results could differ from those estimates.
Recent accounting pronouncements
In May 2014, the Financial Accounting Standard Board, or FASB, issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers: Topic 606 (“ASU 2014-09”) to supersede nearly all existing revenue recognition guidance under generally accepted accounting principles in the United States, or GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. ASU 2014-09 defines a five steps process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for the fiscal and interim reporting periods beginning after December 15, 2017 using either of two methods: (i) retrospective to each prior reporting period presented within the option to elect certain practical expedients as defined within ASU 2014-09; or (ii) retrospective with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application and providing certain additional disclosures as defined per ASU 2014-09. We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements. We will be required to make additional disclosures under the new guidance. However, at this time, we do not expect adoption of ASU 2014-09 will have a material impact on our consolidated financial statements.
In July 2015, FASB issued Accounting Standards Update No. 2015-11, Simplifying the Measurement of Inventory: Topic 330 (“ASU 2015-11”), to amend Topic 330, Inventory. Topic 330 currently requires an entity to measure inventory at the lower of cost or market. Market could be replacement cost, net realizable value, or net realizable value less an approximately normal profit margin. ASU 2015-11 requires that inventory measured using either the first-in, first-out, or FIFO, or average cost method be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. We will adopt ASU 2015-11 as required in our 2017 interim and annual reporting periods. We adopted ASU 2015-11 during 2017 without a material impact on our consolidated financial statements.
In November 2015, FASB issued Accounting Standards Update No. 2015-17, Balance Sheet Classification of Deferred Taxes: Topic 740 (“ASU 2015-17”). Current GAAP requires the deferred taxes for each jurisdiction to be presented as a net current asset or liability and net noncurrent asset or liability. This requires a jurisdiction-by-jurisdiction analysis based on the classification of the assets and liabilities to which the underlying temporary differences relate, or, in the case of loss or credit carryforwards, based on the period in which the attribute is expected to be realized. Any valuation allowance is then required to be allocated on a pro rata basis, by jurisdiction, between current and noncurrent deferred tax assets. The new guidance requires that all deferred tax assets and liabilities, along with any related valuation allowance, be classified as noncurrent on the balance sheet. As a result, each jurisdiction will now only have one net noncurrent deferred tax asset or liability. The guidance does not change the existing requirement that only permits offsetting within a jurisdiction. We adopted ASU 2015-17 during 2016 and subsequent to our adoption, all of our deferred tax assets and liabilities, along with any related valuation allowance, will be classified as noncurrent on our Consolidated Balance Sheet. In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases: Topic 842 (“ASU 2016-2”), which supersedes Accounting Standards Update Topic 840, Leases. ASU 2016-2 requires lessees to recognize a lease liability and a lease asset for all leases, including operating leases, with a term greater than twelve months to its balance sheets. ASU 2016-2 also expands the required quantitative and qualitative disclosures surrounding leases. ASU 2016-2 is effective for the Company beginning January 1, 2019. Early adoption is permitted. The Company is currently evaluating the potential impact the adoption of ASU 2016-2 will have on its consolidated financial statements.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments: Credit Losses that changes the impairment model for most financial instruments, including trade receivables from an incurred loss method to a new forward-looking approach, based on expected losses. The estimate of expected credit losses will require entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts. This ASU is effective for us in the first quarter of 2020 and must be adopted using a modified retrospective transition approach. The Company is currently evaluating the potential impact the adoption of ASU 2016-13 will have on its consolidated financial statements.
In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments that clarifies how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The ASU is effective for us in the first quarter of 2018 with early adoption permitted and must be applied retrospectively to all periods presented. The Company is currently evaluating the potential impact the adoption of ASU 2016-15 will have on its consolidated financial statements.
2. Inventory
Inventory consisted of the following (in thousands):
| | | | | | |
| | March 31, 2017 | | December 31, 2016 |
Finished goods | | $ | 1,402 | | $ | 1,180 |
Raw materials | | | 725 | | | 670 |
| | $ | 2,127 | | $ | 1,850 |
Finished goods primarily include product ready for shipment, as well as promotional merchandise held for sale. Raw materials primarily include ingredients, concentrate and packaging.
3. Line of Credit
We have a revolving secured Loan Facility with CapitalSource Business Finance Group (“CapitalSource”), pursuant to which we, through our Subsidiaries, may borrow a maximum aggregate amount of up to $3.2 million, subject to satisfaction of certain conditions.The current term of the Loan Facility expires on December 27, 2017, unless renewed.
Under the Loan Facility, we may periodically request advances equal to the lesser of: (a) $3.2 million, or (b) the Borrowing Base which is, in the following priority, the sum of: (i) 85% of eligible U.S. accounts receivable, plus (ii) 35% of finished goods inventory not to exceed $475,000, plus (iii) 50% of eligible Canadian accounts receivable not to exceed
$300,000, subject to any reserve amount established by CapitalSource. As of March 31, 2017, our accounts receivable and inventory eligible borrowing base was approximately $1.9 million, of which we had drawn down approximately $634,000.
As amended by the December 2016 renewal, advances under the Loan Facility bear interest at the prime rate plus 0.75%, where prime may not be less than 0%, and a loan fee of 0.10% on the daily loan balance is payable monthly. The Loan Facility provides for a minimum cumulative amount of interest of $30,000 per year to be paid to CapitalSource, regardless of whether or not we draw on the Loan Facility. CapitalSource has the right to terminate the Loan Facility at any time upon 120 days’ prior written notice. All present and future obligations of the Subsidiaries arising under the Loan Facility are guaranteed by us and are secured by a first priority security interest in all of our assets. The Loan Facility contains customary representations and warranties as well as affirmative and negative covenants. As of March 31, 2017, we were in compliance with all covenants under the Loan Facility. The draws on the Loan Facility were used to fulfill working capital needs. We will continue to utilize the Loan Facility, as needed, for working capital needs in the future.
4. Warrants
As part of our registered offering in February 2012, we sold and issued warrants for the purchase of up to 3,207,500 shares of common stock. Each warrant has an exercise price of $0.70 per share, for total potential proceeds to us of up to $2,245,250 if all of the warrants are exercised in full and in cash. The warrants are exercisable for cash or, solely in the absence of an effective registration statement, by cashless exercise. The exercise price of the warrants is subject to adjustment in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions, and also upon any distributions to Company shareholders, business combinations, sale of substantially all assets and other fundamental transactions. The exercise of the warrants is subject to certain beneficial ownership limitations and other restrictions set forth in the warrant documents. The term of the warrants expires on August 6, 2017. Any remaining warrants that are outstanding on August 6, 2017, the expiration date, will automatically be exercised at that time by cashless exercise (if volume weighted average trading price of our common stock as of such date exceeds $0.70 per share).
As of March 31, 2017, 3,057,500 of the warrants remain outstanding. No warrants were exercised during the three months ended March 31, 2017.
5.Shareholders’ Equity
Under the terms of our 2011 Incentive Plan (the “Plan”), the number of shares authorized under the Plan may be increased each January 1st by an amount equal to the least of (a) 1,300,000 shares, (b) 4.0% of our outstanding common stock as of the end of our immediately preceding fiscal year, and (c) a lesser amount determined by the Board of Directors (the “Board”), provided that the number of shares that may be granted pursuant to awards in a single year may not exceed 10% of our outstanding shares of common stock on a fully diluted basis as of the end of the immediately preceding fiscal year. Effective January 1, 2017, the total number of shares of common stock authorized under the Plan increased to a total of 10,784,032 shares.
Under the terms of the Plan, the Board may grant awards to employees, officers, directors, consultants, agents, advisors and independent contractors. Awards may consist of stock options, stock appreciation rights, stock awards, restricted stock, stock units, performance awards or other stock or cash-based awards. Stock options are granted at the closing price of our stock on the date of grant, and generally have a ten-year term and vest over a period of 48 months with the first 25.0% cliff vesting one year from the grant date and the remaining 75.0% vesting in equal monthly increments thereafter. As of March 31, 2017, there were 5,023,938 shares of unissued common stock authorized and available for future awards under the Plan.
A summary of our stock option activity is as follows:
| | | | | |
| | Outstanding Options |
| | Number of Shares | | Weighted Average Exercise Price |
Balance at January 1, 2017 | | 3,663,716 | | $ | 0.54 |
Options granted | | 315,000 | | | 0.45 |
Options exercised | | (38,646) | | | 0.40 |
Balance at March 31, 2017 | | 3,940,070 | | $ | 0.54 |
Exercisable, March 31, 2017 | | 2,771,985 | | $ | 0.56 |
Vested and expected to vest | | 3,654,733 | | $ | 0.54 |
(b)Stock-based compensation expense:
Stock-based compensation expense is recognized using the straight-line attribution method over the employees’ requisite service period. We recognize compensation expense for only the portion of stock options or restricted stock expected to vest. Therefore, we apply estimated forfeiture rates that are derived from historical employee termination behavior. If the actual number of forfeitures differs from those estimated by management, additional adjustments to stock-based compensation expense may be required in future periods.
At March 31, 2017, we had unrecognized compensation expense related to stock options of $232,000 to be recognized over a weighted-average period of 2.6 years.
The following table summarizes the stock-based compensation expense attributable to stock options (in thousands):
| | | | | | |
| | Three months ended March 31, |
| | 2017 | | 2016 |
Income statement account: | | | | | | |
Selling and marketing | | $ | 16 | | $ | 11 |
General and administrative | | | 26 | | | 18 |
| | $ | 42 | | $ | 29 |
We employ the following key weighted-average assumptions in determining the fair value of stock options, using the Black-Scholes option pricing model and the simplified method to estimate the expected term of “plain vanilla” options:
| | | | | | | | |
| | Three months ended March 31, |
| | 2017 | | 2016 |
Expected dividend yield | | | — | | | | — | |
Expected stock price volatility | | | 74.0 | % | | | 87.9 | % |
Risk-free interest rate | | | 2.0 | % | | | 1.7 | % |
Expected term (in years) | | | 5.2 | years | | | 6.1 | years |
Weighted-average grant date fair-value | | $ | 0.28 | | | $ | 0.34 | |
The aggregate intrinsic value of stock options outstanding at March 31, 2017 and 2016 was $210,000 and $953,000 and for options exercisable was $188,000 and $482,000, respectively. The intrinsic value of outstanding and exercisable stock options is calculated as the quoted market price of the stock at the balance sheet date less the exercise price of the option. There were 38,646 options exercised during the three months ended March 31, 2017. The aggregate intrinsic value of the options exercised during the three months ended March 31, 2017 was $3,000.
6. Segment Information
We have one operating segment with operations primarily in the United States and Canada. Sales are assigned to geographic locations based on the location of customers. Sales by geographic location are as follows (in thousands):
| | | | | | |
| | Three months ended March 31, |
| | 2017 | | 2016 |
Revenue: | | | | | | |
United States | | $ | 2,705 | | $ | 3,565 |
Canada | | | 681 | | | 684 |
Other countries | | | 149 | | | 25 |
Total revenue | | $ | 3,535 | | $ | 4,274 |
During the three months ended March 31, 2017 and 2016, three and four of our customers represented approximately 53% and 59%, respectively, of revenue.
ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
You should read the following discussion and analysis in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Report and the 2016 audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission (SEC) on March 23, 2017.
This Report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “believe,” “expect,” “intend,” “anticipate,” “estimate,” “may,” “will,” “can,” “plan,” “predict,” “could,” “future,” “continue,” variations of such words, and similar expressions. These statements are only predictions. Actual events or results may differ materially. In evaluating these statements, you should specifically consider various factors, including the risks outlined at the beginning of this report under “Cautionary Notice Regarding Forward-Looking Statements” and in Item 1A of our most recent Annual Report on Form 10-K filed with the SEC. These factors may cause our actual results to differ materially from any forward-looking statements. Except as required by law, we undertake no obligation to publicly release any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Overview
We develop, produce, market and distribute premium beverages which we sell and distribute primarily in the United States and Canada through our network of independent distributors and directly to our national and regional retail accounts. We also sell products in select international markets. Our products are sold in grocery stores, convenience and gas stores, on fountain in restaurants, “up and down the street” in independent accounts such as delicatessens and sandwich shops, as well as through our national accounts with several large retailers. We refer to our network of independent distributors as our direct store delivery (DSD) channel, and we refer to our national and regional accounts who receive shipments directly from us as our direct to retail (DTR) channel. We do not directly manufacture our products, but instead outsource the manufacturing process to third-party contract manufacturers. We also sell various products online, including soda with customized labels, wearables, candy and other items, and we license our trademarks for use on products sold by other manufacturers.
Our Focus: Sales Growth
Our focus is sales growth through the execution of the following key initiatives:
| · | | Build upon partnerships in innovative ways; |
| · | | Expand our fountain program in the United States and Canadian marketplaces; |
| · | | Build Lemoncocco sales in select markets in the United States and Canada; |
| · | | New product innovation; and |
| · | | Explore accretive acquisitions in the food and beverage industry. |
Results of Operations
The following selected financial and operating data are derived from our condensed consolidated financial statements and should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our condensed consolidated financial statements.
| | | | | | | | | | | | |
| | Three months ended March 31, |
| | 2017 | | % of Revenue | | 2016 | | % of Revenue |
Consolidated statements of operations data: | | (Dollars in thousands, except per share data) |
Revenue | | $ | 3,535 | | 100.0 | % | | $ | 4,274 | | 100.0 | % |
Cost of goods sold | | | (2,682) | | (75.9) | % | | | (3,102) | | (72.6) | % |
Gross profit | | | 853 | | 24.1 | % | | | 1,172 | | 27.4 | % |
Selling and marketing expenses | | | (544) | | (15.4) | % | | | (542) | | (12.7) | % |
General and administrative expenses | | | (483) | | (13.7) | % | | | (564) | | (13.2) | % |
Income (loss) from operations | | | (174) | | (4.9) | % | | | 66 | | 1.5 | % |
Interest expense | | | (15) | | (0.4) | % | | | (22) | | (0.5) | % |
Other (expense) income, net | | | (1) | | (0.0) | % | | | 12 | | 0.3 | % |
Income (loss) before income taxes | | | (190) | | (5.4) | % | | | 56 | | 1.3 | % |
Income tax expense, net | | | (7) | | (0.2) | % | | | (7) | | (0.2) | % |
Net income (loss) | | $ | (197) | | (5.6) | % | | $ | 49 | | 1.1 | % |
Basic and diluted net income (loss) per share | | $ | (0.00) | | | | | $ | 0.00 | | | |
| | | | | | | | | | | | |
| | As of |
| | March 31, 2017 | | December 31, 2016 |
Balance sheet data: | (Dollars in thousands) |
Cash and cash equivalents and accounts receivable, net | | $ | 2,598 | | | $ | 2,907 |
Fixed assets, net | | | 23 | | | | 25 |
Total assets | | | 4,880 | | | | 4,932 |
Long-term liabilities | | | 12 | | | | 12 |
Working capital | | | 1,648 | | | | 1,784 |
| | | | | | | | | |
| | | | | | | | | | | | |
| | |
| | | | |
| | | | | | | | | | | | |
| | | | | | |
Quarter Ended March 31, 2017 Compared to Quarter Ended March 31, 2016
Revenue
For the quarter ended March 31, 2017, revenue was approximately $3.5 million, a decrease of $739,000 or 17.3% from $4.3 million in revenue for the quarter ended March 31, 2016. The decrease is primarily due to timing and price differences between the initial product launch of our co-branded 7-Eleven PET product and the re-launch of the co-branded 7-Eleven glass product. The current co-branded glass product was launched during the fourth quarter of 2016 and the first quarter of 2017, as compared to the significant pipeline fill of the PET co-branded product in the comparable first quarter of 2016. Other one-time factors including timing and SKU selection contributed to a lesser extent.
For the quarter ended March 31, 2017, trade spend and promotion allowances, which offset revenue, totaled $309,000, a decrease of $225,000 or 42.1% primarily due to costs associated with one-time programs in the prior year.
Gross Profit
For the quarter ended March 31, 2017, gross profit decreased by $319,000 or 27.2%, to approximately $853,000 compared to $1,172,000 for the quarter ended March 31, 2016 due to timing variances of a product launch. For the quarter ended March 31, 2017 gross margin as a percentage of revenue decreased to 24.1% from 27.4% for the quarter ended March 31, 2016.
Selling and Marketing Expenses
Selling and marketing expenses for the quarter ended March 31, 2017 were $544,000, an increase of $2,000 or 0.4%, from $542,000 for the quarter ended March 31, 2016. Selling and marketing expenses as a percentage of revenue increased to 15.4% for the quarter ended March 31, 2017, from 12.7% in 2016. We will continue to balance selling and marketing expenses with our working capital resources. For the three months ended March 31, 2017 and 2016, non-cash expenses included in selling and marketing expense (stock compensation and depreciation) were $17,000 and $14,000, respectively.
General and Administrative Expenses
General and administrative expenses for the quarter ended March 31, 2017 were $483,000, a decrease of $81,000 or 14.4%, compared to $564,000 for the quarter ended March 31, 2016, due to the timing of one-time charges during the prior year. General and administrative expenses as a percentage of revenue remained relatively flat at 13.7% for the quarter ended March 31, 2017, compared to 13.2% in 2016. We will continue to carefully manage general and administrative expenses with our working capital resources. For the three months ended March 31, 2017 and 2016, non-cash expenses included in general and administrative expense (stock compensation and depreciation) were $27,000 and $19,000, respectively.
Income Tax Expense
We had $7,000 income tax expense for both the quarters ended March 31, 2017 and 2016, primarily related to the tax provision on income from our Canadian operations. We have not recorded any tax benefit for the loss in our U.S. operations as we have recorded a full valuation allowance on our U.S. net deferred tax assets. We expect to continue to record a full valuation allowance on our U.S. net deferred tax assets until we sustain an appropriate level of taxable income through improved U.S. operations. Our effective tax rate is based on recurring factors, including the forecasted mix of income before taxes in various jurisdictions, estimated permanent differences and the recording of a full valuation allowance on our U.S. net deferred tax assets.
Net (loss) income
Net loss for the quarter ended March 31, 2017 was $197,000 compared to net income of $49,000 for the quarter ended March 31, 2016 due to the timing of new product offerings.
Liquidity and Capital Resources
As of March 31, 2017, we had cash and cash equivalents of approximately $554,000 and working capital of $1.6 million. Cash provided by operations during the three months ended March 31, 2017 totaled $371,000 compared to cash used in operations of $67,000 for the same period a year ago. The increase in cash provided by operations compared to the same period a year ago is primarily due to the timing of production and certain receivables. We had a net loss of $197,000 for the three months ended March 31, 2017.
As of the date of this Report, we believe that our current cash and cash equivalents, combined with our Loan Facility and anticipated cash from operations, will be sufficient to meet our anticipated working capital requirements through March 31, 2018.
We have a revolving secured credit facility with CapitalSource Business Finance Group. The Loan Facility currently allows us to borrow a maximum aggregate amount of up to $3.2 million based on eligible accounts receivable and inventory. As of March 31, 2017, our accounts receivable and inventory eligible borrowing base was approximately $1.9 million, of which we had drawn down $634,000. We intend use the Loan Facility for our working capital needs. The Loan Facility is available for future borrowing, as discussed further in Note 3 of our Condensed Consolidated Financial Statements.
We may require additional financing to support our working capital needs in the future. The amount and timing of our additional capital requirements and the availability to fund those requirements will depend on a number of factors, including our strategic initiatives and operating plans, the performance of our business and the market conditions for available debt or equity financing. Additionally, the amount of capital required will depend on our ability to meet our case sales goals and otherwise successfully execute our operating plan. We believe it is imperative that we meet these sales objectives in order to lessen our reliance on external financing in the future. We intend to continually monitor and adjust our business plan as necessary to respond to developments in our business, our markets and the broader economy. Although we believe various debt and equity financing alternatives will be available to us to support our working capital needs, financing arrangements on acceptable terms may not be available to us when needed. Additionally, these alternatives may require significant cash payments for interest and other costs or could be highly dilutive to our existing shareholders. Any such financing alternatives may not provide us with sufficient funds to meet our long-term capital requirements. If necessary, we may explore strategic transactions that we consider to be in the best interest of the Company and our shareholders, which may include, without limitation, public or private offerings of debt or equity securities, a rights offering, and other strategic alternatives; however, these options may not ultimately be available or feasible.
The uncertainties relating to our ability to successfully execute on our business plan and finance our operations continue to raise substantial doubt about our ability to continue as a going concern. Our financial statements for the periods presented were prepared assuming we would continue as a going concern, which contemplates that we will continue in operation for the foreseeable future and will be able to realize assets and settle liabilities and commitments in the normal course of business. These financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that could result should we be unable to continue as a going concern.
Seasonality and other Fluctuations
Our sales are seasonal and we experience fluctuations in quarterly results as a result of many factors. We historically have generated a greater percentage of our revenues during the warm weather months of April through September. Sales may fluctuate materially on a quarter to quarter basis or an annual basis when we launch a new initiative or fill the “pipeline” of a new distribution partner or a large retail partner such as 7-Eleven. Sales results may also fluctuate based on the number of SKUs selected or removed by our distributors and retail partners through the normal course of serving consumers in the dynamic, trend-oriented beverage industry. As a result, management believes that period-to-period comparisons of results of operations are not necessarily meaningful and should not be relied upon as any indication of future performance or results expected for the fiscal year.
Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements.
Critical Accounting Policies
See the information concerning our critical accounting policies included under “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation – Critical Accounting Policies” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016, filed with the Securities Exchange Commission on March 23, 2017. There have been no material changes in our critical accounting policies during the three months ended March 31, 2017.
ITEM 4. CONTROLS AND PROCEDURES.
Procedures
(a) Evaluation of disclosure controls and procedures
We maintain disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended). Management, under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(b) as of March 31, 2017. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that these disclosure controls and procedures were effective as of March 31, 2017.
(b) Changes in internal controls
There were no changes in our internal controls over financial reporting during the three months ended March 31, 2017 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.
PART II – OTHER INFORMATION
ITEM 1.LEGAL PROCEEDINGS
We are or may be involved from time to time in various claims and legal actions arising in the ordinary course of business, including proceedings involving employee claims, contract disputes, product liability and other general liability claims, as well as trademark, copyright, and related claims and legal actions. In the opinion of our management, the ultimate disposition of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.
ITEM 5. OTHER INFORMATION
2017 Annual Meeting - Submission of Matters to a Vote of Shareholders
At our 2017 Annual Meeting of Shareholders held on May 10, 2017, the following matters were submitted to a vote of our shareholders:
The shareholders elected the following five directors, who received the number of votes set forth opposite their respective names:
| | | | | |
| For | | Withheld | | Broker Non-Votes |
| | | | | |
Richard V. Cautero | 8,178,694 | | 503,702 | | 26,502,252 |
Jennifer L. Cue | 8,427,315 | | 255,081 | | 26,502,252 |
Michael M. Fleming | 7,930,835 | | 751,561 | | 26,502,252 |
Matthew K. Kellogg | 7,940,342 | | 742,054 | | 26,502,252 |
Susan A. Schreter | 7,918,038 | | 764,358 | | 26,502,252 |
The shareholders ratified the appointment of Peterson Sullivan LLP as our independent registered public accounting firm for the fiscal year 2017 by a vote of 33,434,380 shares For, 1,396,808 shares Against, and 248,475 shares abstaining. There were no broker non-votes in connection with this matter.
The shareholders approved a non-binding advisory resolution (commonly referred to as a “say-on-pay” resolution) on our executive compensation for fiscal year 2016 by a vote of 7,845,385 shares For, 574,763 shares Against, and 157,263 shares abstaining. There were 26,502,252 broker non-votes in connection with this matter.
ITEM 6.EXHIBITS
| | |
3.1 | | Articles of Incorporation of Jones Soda Co. (Previously filed with, and incorporated herein by reference to, Exhibit 3.1 to our annual report on Form 10-KSB for the fiscal year ended December 31, 2000, filed on March 30, 2001; File No. 333-75913). |
3.2 | | Amended and Restated Bylaws of Jones Soda Co. (Previously filed with, and incorporated herein by reference to, Exhibit 3.1 to our quarterly report on Form 10-Q, filed on November 8, 2013) |
10.5 | | Amendment & Restatement of First Modification to Loan and Security Agreement dated as of December 22, 2014, by and among Jones Soda Co. (USA) Inc., JONES SODA (CANADA) Inc., and CapitalSource Business Finance Group, a dba of BFI Business Finance (Previously filed with, and incorporated herein by reference to Exhibit 10.1 to our current report on Form 8-K, filed December 23, 2014.) |
10.6 | | Second Modification to Loan and Security Agreement dated as of May 13, 2015, by and among Jones Soda Co. (USA) Inc., JONES SODA (CANADA) Inc., and CapitalSource Business Finance Group, a dba of BFI Business Finance (Previously filed with, and incorporated herein by reference to, Exhibit 10.2 to our current report on Form 8-K, filed January 7, 2016.) |
10.7 | | Third Modification to Loan and Security Agreement dated as of December 18, 2015, by and among Jones Soda Co. (USA) Inc., JONES SODA (CANADA) Inc., and CapitalSource Business Finance Group, a dba of BFI Business Finance (Previously filed with, and incorporated herein by reference to, Exhibit 10.1 to our current report on Form 8-K, filed January 7, 2016.) |
10.8 | | Fourth Modification of Loan and Security Agreement dated as of December 16, 2016, by and among Jones Soda Co. (USA) Inc., JONES SODA (CANADA) Inc., and CapitalSource Business Finance Group, a dba of BFI Business Finance (Previously filed with, and incorporated herein by reference to, Exhibit 10.1 to our current report on Form 8-K, filed January 3, 2017.) |
31.1 | | Certification by Jennifer L. Cue, Chief Executive Officer, pursuant to Rule 13a-14(a), pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Filed herewith.) |
31.2 | | Certification by Max Schroedl, Chief Financial Officer and Principal Financial Officer, pursuant to Rule 13a-14(a), pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Filed herewith.) |
32.1 | | Certification by Jennifer L. Cue, Chief Executive Officer and Max Schroedl, Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Filed herewith.) |
101.INS** | | XBRL Instance Document. |
101.SCH** | | XBRL Taxonomy Extension Schema Document. |
101.CAL** | | XBRL Taxonomy Extension Calculation Linkbase Document. |
101.DEF** | | XBRL Taxonomy Extension Definition Linkbase Document. |
101.LAB** | | XBRL Taxonomy Extension Label Linkbase Document. |
101.PRE** | | XBRL Taxonomy Extension Presentation Linkbase Document. |
* Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
May 12, 2017
| | |
| JONES SODA CO. |
| By: | /s/ Jennifer L. Cue |
| | Jennifer L. Cue |
| | Chief Executive Officer |
| | |
| JONES SODA CO. |
| By: | /s/ Max Schroedl |
| | Max Schroedl |
| | Chief Financial Officer |